HEPATOTOXICITY
See full prescribing information for complete boxed warning.
- TRADE NAME: Mylotarg (Wyeth)
- INDICATIONS: Acute myeloid leukemia
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Monoclonal antibody
- HALF-LIFE: 45 hours (initial dose)
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
